Objective: This study reports on the influence of migraine and comorbid dep
ression on health-related quality of life (HRQoL) in a population-based sam
ple of subjects with migraine and nonmigraine controls. Methods: Two popula
tion-based studies of similar design were conducted in the United States an
d United Kingdom. A clinically validated, computer-assisted telephone inter
view was used to identify individuals with migraine, as defined by the Inte
rnational Headache Society, and a nonmigraine control group. During follow-
up interviews, 389 migraine cases (246 US, 143 UK) and 379 nonmigraine cont
rols (242 US, 137 UK) completed the Short Form (SF)-12, a generic HRQoL mea
sure, and the Primary Care Evaluation of Mental Disorders, a mental health
screening tool. The SF-12 measures HRQoL in two domains: a mental health co
mponent score (MCS-12) and a physical health component score (PCS-12). Resu
lts: In the United States and United Kingdom, subjects with migraine had lo
wer scores (p < 0.001) on both the MCS-12 and PCS-12 than their nonmigraine
counterparts. Significant differences were maintained after controlling fo
r gender, age, and education. Migraine and depression were highly comorbid
(adjusted prevalence ratio 2.7, 95% CI 2.1 to 3.5). After adjusting for gen
der, age, and education, both depression sand migraine remained significant
ly and independently associated with decreased MCS-12 and PCS-12 scores. HR
QoL was significantly associated with attack frequency (for MCS-12 and PCS-
12) and disability (MCS-12). Conclusions: Subjects with migraine selected f
rom the general population have lower HRQoL as measured by the SF-12 compar
ed with nonmigraine controls. Further, migraine and depression are highly c
omorbid and each exerts a significant and independent influence on HRQoL.